Which characteristic is associated with Dorzolamide?

Dorzolamide is classified as a carbonic anhydrase inhibitor. This characteristic is significant because carbonic anhydrase is an enzyme that plays a crucial role in the hydration of carbon dioxide and the regulation of acid-base balance in various tissues. In the context of ocular pharmacology, inhibiting this enzyme in the ciliary body of the eye decreases the production of aqueous humor, leading to a reduction in intraocular pressure, which is beneficial for treating conditions such as glaucoma.

This mechanism distinguishes Dorzolamide from the other options listed. For example, prostaglandin analogs work by increasing the outflow of aqueous humor, non-selective beta blockers reduce aqueous humor production but not through carbonic anhydrase inhibition, and alpha agonists also target different pathways to lower intraocular pressure. Understanding the specific action of Dorzolamide helps in recognizing its therapeutic application in managing elevated intraocular pressure.